Karista

Karista is a venture capital firm established in 2001 and located in Paris, France. The firm specializes in incubation and early-stage investments, focusing on a diverse range of sectors including healthcare, information and communication technology, nanotechnology, and clean technology. It actively invests in startups engaged in biotechnology, medical equipment, digital technologies, deep tech, and newspace, among other areas. Karista typically directs investments ranging from €0.5 million to €5 million in companies with revenues up to €4 million. The firm primarily operates within France, particularly in the Ile-de-France region and Paris, and has supported over 90 companies over the past two decades, emphasizing partnerships with entrepreneurs who share a common vision.

Tom Beauvironnet

Investment Manager

Catherine Boule

Managing Partner, Healthcare Practice

Luca Brilliet

Investment Manager

Emmanuel Daugeras

Investment Director

Olivier Dubuisson

Co-Founder and Managing Partner

Yvan-Michel Ehkirch

Managing Partner

Baudouin Hue

Partner

153 past transactions

SamanTree Medical

Series B in 2025
SamanTree Medical SA is a Swiss medical microscopy device company specializing in advanced micro-optics based digital microscopy systems designed for research, diagnostic, and surgical applications. Founded in 2014 and located in Ecublens, Switzerland, the company focuses on enhancing cancer treatment through innovative imaging solutions. Its flagship product is a surgical digital microscope that enables real-time visualization of the cellular structure of living tissue, allowing surgeons to accurately assess tumor margins during procedures. This technology facilitates improved surgical treatment decisions, enhances resection accuracy, and helps reduce re-operation rates, ultimately lowering the overall costs associated with surgical interventions. By providing histology-grade confidence and full margin control during lumpectomies, SamanTree Medical aims to significantly improve patient care and outcomes in cancer surgery.

BforeAI

Series B in 2024
BforeAI specializes in proactive cybersecurity solutions, utilizing predictive attack intelligence and digital risk protection services. Powered by its proprietary PreCrime™ technology featuring behavioral AI, BforeAI transforms traditional reactive cyber defense into a proactive approach. The company offers automated threat intelligence, brand protection, adversary disruption, and domain takedowns to swiftly and precisely defend against online fraud. Recognized by Gartner in multiple reports and awarded by the FinTech Innovation Lab New York, BforeAI stands out for its innovative predictive cybersecurity software designed to anticipate and mitigate potential threats before they occur.

Brightflow

Series A in 2024
Brightflow operates as a medical device startup.

Deemea

Seed Round in 2024
Deemea is a developer of a digital medical assistance platform that focuses on enhancing clinical research and the analysis of real-world data. The company utilizes artificial intelligence to streamline various processes, including identifying appropriate databases, expediting contractual and regulatory tasks, and simplifying external model validation. Deemea's platform aims to optimize responses to both internal and external inquiries while valorizing real-world data and clinical studies. By integrating these capabilities, Deemea helps clients accelerate the development and deployment of innovative projects, ensuring efficiency and reliability in the management of imaging data within the clinical research landscape.

BforeAI

Series A in 2024
BforeAI specializes in proactive cybersecurity solutions, utilizing predictive attack intelligence and digital risk protection services. Powered by its proprietary PreCrime™ technology featuring behavioral AI, BforeAI transforms traditional reactive cyber defense into a proactive approach. The company offers automated threat intelligence, brand protection, adversary disruption, and domain takedowns to swiftly and precisely defend against online fraud. Recognized by Gartner in multiple reports and awarded by the FinTech Innovation Lab New York, BforeAI stands out for its innovative predictive cybersecurity software designed to anticipate and mitigate potential threats before they occur.

10Lines

Series A in 2024
10Lines focuses on the development of autonomous robots aimed at enhancing efficiency in the pavement marking industry, particularly for parking lot layouts. The company's innovative solutions enable striping businesses to complete their work more rapidly while reducing their environmental impact. By utilizing these advanced technologies, striping companies can significantly increase productivity, allowing them to accomplish more tasks with the same workforce. This approach not only streamlines operations but also promotes sustainability in the striping process.

Heex Technologies

Seed Round in 2024
Heex Technologies is a data management platform designed to support engineering teams in transitioning from traditional Big Data to more efficient Smart Data. The company focuses on automating data pipelines and workflows, allowing organizations to extract relevant data efficiently, either at the edge or in the cloud. This capability not only enhances productivity but also helps businesses optimize costs and resources. As companies increasingly demand precise information, Heex Technologies addresses the challenges posed by the diminishing returns of conventional AI development, ensuring that teams can access and utilize the most pertinent data seamlessly.

Kranus Health

Series A in 2023
Kranus Health is a prominent global provider of virtual care in the field of Urology, specializing in clinically validated therapies for various conditions, including Andrology and Uro-Oncology. The company operates a digital health platform designed to assist men in overcoming issues such as erectile dysfunction and nausea. Its comprehensive platform features pelvic floor training, cardiovascular training, mental training, medical supervision, and preventive therapies, allowing patients to manage their health conditions from home. By focusing on innovative solutions, Kranus Health aims to improve patients' quality of life and promote healthier, longer lives.

constellr

Seed Round in 2023
Constellr is a company that develops advanced imaging technology for the agriculture sector, focusing on evaluating soil health, vegetation, and industrial monitoring through proprietary space infrastructure. By measuring critical factors such as water, temperature, and carbon, Constellr provides essential data that supports high-precision smart farming services, thereby contributing to global food security. The company addresses climate change by offering accountability and monitoring solutions across multiple markets. Its technology underpins various remote sensing products, including models for evapotranspiration, water stress, and crop yield prediction, enabling farmers, agronomists, agricultural companies, and infrastructure managers to gain precise insights and make informed decisions.

Look Up Space

Seed Round in 2023
Look Up Space specializes in delivering high-quality space safety and security data and services aimed at helping organizations effectively manage space-related risks. The company employs a dedicated, sovereign, and secure sensor network, complemented by advanced data processing capabilities. This infrastructure enables Look Up Space to provide real-time data and services, empowering businesses to enhance their understanding of space safety and make informed decisions regarding risk management in the evolving space environment.

Beev

Seed Round in 2023
Beev is a mobility platform based in Paris, France, founded in 2020, that focuses on providing electric vehicle solutions for both individuals and businesses. The company facilitates the decarbonization of mobility through its online automotive platform, which streamlines the entire process from vehicle purchase to the installation of charging stations. Beev emphasizes user-friendly features such as online signatures, price transparency, and flexible payment options, allowing customers to save time and money while acquiring electric vehicles and charging infrastructure for various settings, including homes, businesses, and public spaces.

Exotrail

Series B in 2023
Exotrail, established in 2015 and based in Palaiseau, France, specializes in developing electric propulsion systems and flight software for small satellites and constellations. The company's key products are ExoMS, a propulsion system enabling small satellite constellations to access new orbits, and ExoOPS, a cloud-based software for mission operation planning. Exotrail's electric thrusters cater to nano and micro-satellites, serving applications in telecommunication, earth observation, and space science.

Heex Technologies

Pre Seed Round in 2022
Heex Technologies is a data management platform designed to support engineering teams in transitioning from traditional Big Data to more efficient Smart Data. The company focuses on automating data pipelines and workflows, allowing organizations to extract relevant data efficiently, either at the edge or in the cloud. This capability not only enhances productivity but also helps businesses optimize costs and resources. As companies increasingly demand precise information, Heex Technologies addresses the challenges posed by the diminishing returns of conventional AI development, ensuring that teams can access and utilize the most pertinent data seamlessly.

BforeAI

Series A in 2022
BforeAI specializes in proactive cybersecurity solutions, utilizing predictive attack intelligence and digital risk protection services. Powered by its proprietary PreCrime™ technology featuring behavioral AI, BforeAI transforms traditional reactive cyber defense into a proactive approach. The company offers automated threat intelligence, brand protection, adversary disruption, and domain takedowns to swiftly and precisely defend against online fraud. Recognized by Gartner in multiple reports and awarded by the FinTech Innovation Lab New York, BforeAI stands out for its innovative predictive cybersecurity software designed to anticipate and mitigate potential threats before they occur.

CYSEC

Seed Round in 2022
CYSEC is a startup focused on advancing Confidential Computing solutions that ensure the security of data at rest, in motion, and in use. The company has developed a cloud-based data security software that operates as a physical enterprise-grade server appliance, enabling businesses to safeguard their assets and maintain the integrity and confidentiality of data stored in the cloud. CYSEC's flagship product, the ARCA solution, has gained popularity in the market due to its ability to support multiple applications and enhance cybersecurity across various sectors. By providing innovative tools for confidential computing, CYSEC aims to empower organizations to develop cutting-edge technological solutions while ensuring robust data protection.

Incepto

Venture Round in 2022
Incepto Medical SAS, established in 2018 and headquartered in Paris, France, specializes in developing and distributing artificial intelligence (AI) applications for medical imaging. Its portfolio includes software solutions like Qure.ai qER and qXR for head CT and thorax abnormality detection, Aidence Veye Chest for pulmonary nodule tracking, Icometric Icobrain for neurological disorder monitoring, and ScreenPoint Transpara for breast cancer detection. Additionally, Incepto operates Collective Minds Radiology, an online platform fostering case support, opinion sharing, and learning among healthcare professionals. The company aims to empower medical practitioners by providing AI-driven tools that address the challenges posed by increasing patient volumes and image data.

TRiCares

Series C in 2022
TRiCares is a medical device company focused on creating innovative solutions for tricuspid valve regurgitation. The company specializes in developing a catheter-based valve replacement system that facilitates minimally invasive treatments for patients suffering from tricuspid insufficiency. By emphasizing anatomical conformation and user-friendly design, TRiCares aims to provide effective and durable treatment options that improve patient outcomes. Through its advancements in medical technology, TRiCares addresses a critical need in cardiology, enhancing the quality of care for those affected by this condition.

Ludocare

Seed Round in 2022
Ludocare is a company focused on developing therapeutic robots aimed at assisting patients with chronic diseases and their families. Its innovative devices are designed to complement traditional drug treatments by providing personalized support that empowers patients, particularly children, to enhance their treatment compliance and overall quality of life. By improving patients' abilities and autonomy, Ludocare's solutions seek to foster better disease management and stabilization of essential treatments, ultimately aiming to improve the efficiency of healthcare delivery for those affected by chronic conditions.

Vestack

Series A in 2022
Vestack is a PropTech company focused on the design and manufacture of low-carbon buildings utilizing bio-sourced materials. It employs a modular construction system that allows for pre-assembly on-site, catering to a variety of architectural shapes and land plot constraints. The company serves as a general contractor for real estate developers, providing solutions for both residential and public buildings across diverse price ranges. By integrating proprietary software and hardware technology, Vestack enhances the construction process, ensuring rapid production while significantly reducing the environmental impact of its structures. Its approach combines digital design and modular manufacturing to promote the development of healthy and sustainable buildings.

Leanspace

Seed Round in 2022
Leanspace is a developer of an integrated cloud platform tailored for public and private space organizations. The company offers a unique approach to building space software by providing essential functions via APIs, allowing organizations to streamline their ground software infrastructures effectively. This platform enables users to develop only the necessary functionalities in-house, significantly reducing both time and costs while maintaining control over their tools. By combining cloud technologies with space engineering concepts, Leanspace enhances agility and competitiveness for its clients. Its systems are designed to be integrated, collaborative, and digital, supporting organizations in optimizing their space missions.

Kranus Health

Series A in 2022
Kranus Health is a prominent global provider of virtual care in the field of Urology, specializing in clinically validated therapies for various conditions, including Andrology and Uro-Oncology. The company operates a digital health platform designed to assist men in overcoming issues such as erectile dysfunction and nausea. Its comprehensive platform features pelvic floor training, cardiovascular training, mental training, medical supervision, and preventive therapies, allowing patients to manage their health conditions from home. By focusing on innovative solutions, Kranus Health aims to improve patients' quality of life and promote healthier, longer lives.

Miratlas

Seed Round in 2022
Miratlas SAS is a French manufacturer specializing in the design and production of advanced atmospheric measurement instruments. Their primary business involves developing integrated sky monitoring devices to enhance understanding of climate change and optimize free-space optical communication between Earth and space. Miratlas offers continuous, real-time atmospheric monitoring services, focusing on cloud cover, turbulence, and absorption, enabling accurate nowcasting of weather conditions for various industries.

Implicity

Series A in 2022
Implicity is a developer of a remote monitoring platform that focuses on patients with connected cardiac implants, such as pacemakers and defibrillators. The company's software-as-a-service (SaaS) platform utilizes artificial intelligence to sort and summarize patient data, assessing the criticality of alerts based on the medical context of each individual. This technology allows cardiologists and healthcare professionals to automate the monitoring process, facilitating efficient oversight of patient health and enhancing the quality of care. By consolidating patient information and alerts on a single platform, Implicity aims to improve the management of cardiac conditions and support hospital teams in delivering optimal patient outcomes.

Humanlinker

Seed Round in 2022
Humanlinker is a technology company that specializes in AI-guided solutions for revenue generation teams. Their platform leverages artificial intelligence algorithms to provide account-based selling strategies, identify strategic accounts ready for assignment, and track relevant data to enhance sales interactions. The company aims to help businesses improve their sales processes by utilizing cutting-edge technology.

Sitowie

Seed Round in 2022
Sitowie is a company that specializes in developing software as a service (SaaS) technology aimed at understanding and managing the degradation of buildings. Utilizing artificial intelligence and machine learning, Sitowie's platform assists clients in anticipating risks associated with the aging of structures. The tools provided by the company not only enhance the sustainability of buildings but also contribute to cost reduction and facilitate effective arbitration processes. By focusing on the preservation and sustainability of heritage properties, Sitowie aims to support clients in making informed decisions regarding building maintenance and management.

i-Lunch

Series A in 2021
i-Lunch offers corporate catering services. I-Lunch provides businesses with adaptable, high-demand, and customized solutions. I-online Lunch's ordering platform offers useful and delectable recipes that are prepared in returnable glass containers and developed jointly by the company's nutritionists and chefs.

MoveUP

Seed Round in 2021
MoveUP is a company focused on developing and commercializing digital therapeutics solutions designed to enhance healthcare delivery. Its innovative platform features a closed-loop system that ensures high compliance and improved outcomes for patients. By continuously collecting data, the platform personalizes treatment plans, significantly enhancing patient satisfaction. MoveUP's initial product targets orthopedic patients recovering from joint surgery, providing a user-friendly medical-grade mobile application that supports faster recovery. The company holds CE medical device and ISO 13485 certifications, underscoring its commitment to quality and regulatory standards in the healthcare sector.

Vestack

Series A in 2021
Vestack is a PropTech company focused on the design and manufacture of low-carbon buildings utilizing bio-sourced materials. It employs a modular construction system that allows for pre-assembly on-site, catering to a variety of architectural shapes and land plot constraints. The company serves as a general contractor for real estate developers, providing solutions for both residential and public buildings across diverse price ranges. By integrating proprietary software and hardware technology, Vestack enhances the construction process, ensuring rapid production while significantly reducing the environmental impact of its structures. Its approach combines digital design and modular manufacturing to promote the development of healthy and sustainable buildings.

Ramdam

Seed Round in 2020
Ramdam is a developer of an innovative digital assistant application that enhances the car buying experience. The application utilizes conversational artificial intelligence to facilitate online car searches, making the process both engaging and efficient. With a user-friendly interface that incorporates a swiper feature, Ramdam aims to make car searching enjoyable and interactive for users. The platform also enables car dealers to effectively advertise their inventory, fostering connections with potential buyers who have shown interest in their listings. Through these features, Ramdam seeks to streamline content creation for creators in the automotive space while providing a modern solution for consumers and dealers alike.

Exotrail

Series A in 2020
Exotrail, established in 2015 and based in Palaiseau, France, specializes in developing electric propulsion systems and flight software for small satellites and constellations. The company's key products are ExoMS, a propulsion system enabling small satellite constellations to access new orbits, and ExoOPS, a cloud-based software for mission operation planning. Exotrail's electric thrusters cater to nano and micro-satellites, serving applications in telecommunication, earth observation, and space science.

Eyevensys

Series B in 2020
Eyevensys S.A.S. is a Paris-based company that specializes in non-viral gene therapy for ophthalmology. Founded in 2008, it focuses on developing innovative solutions to improve drug delivery methods for ocular diseases. The company utilizes its proprietary Electro-Transfection (ET) technology to administer plasmids to the ciliary muscle, allowing for the sustained release of therapeutic proteins directly into the vitreous, addressing conditions such as uveitis, age-related macular degeneration, and various retinopathies, including central retinal vein occlusion and diabetic retinopathy. Eyevensys aims to overcome the limitations of current treatment options, which often involve invasive procedures like intravitreal injections and surgeries. By enhancing compliance, ocular bioavailability, and tolerability, Eyevensys seeks to create a robust product pipeline that delivers improved clinical outcomes while minimizing the need for frequent and invasive interventions.

Tallano

Series A in 2019
Tallano Technologie is a French company based in Boulogne-Billancourt, specializing in the development and manufacture of particle collectors designed to reduce emissions from vehicle braking systems. Founded in 2012, the company has pioneered technology that captures harmful particles at the source through a suction mechanism. Their flagship product, known as tamic, is positioned between the brake disc and pad in both private cars and public transport vehicles, effectively mitigating the release of particulate matter into the environment. Tallano's innovative approach addresses a critical concern in automotive emissions, contributing to cleaner air and enhanced sustainability in urban transportation.

UpFactor

Seed Round in 2019
UpFactor is an independent consultancy firm based in Paris, France, established in 2017. The company specializes in site analysis and the large-scale detection of aerial land potential, providing essential services to the real estate and construction sectors. UpFactor utilizes a geographic information system that aggregates comprehensive data necessary for assessing building possibilities, including addresses, street widths, building heights, planning land use, solar land registers, and protected areas. Its expertise allows property owners to enhance their existing structures by increasing the number of floors, thereby expanding usable space and addressing growing demands in developed areas while promoting sustainable development practices.

TISSIUM

Series B in 2019
TISSIUM is a medical device company headquartered in Paris, France, focused on the development and commercialization of innovative biodegradable sealants and adhesives for surgical wound closure, particularly in minimally invasive procedures. The company's products are designed to be non-toxic, provide strong adhesion to tissues, and enable rapid wound closure in the body's dynamic environments. TISSIUM leverages advanced research and intellectual property from renowned laboratories, including those of Robert Langer at MIT and Jeff Karp at Brigham and Women’s Hospital. Its technology platform includes a proprietary family of fully biosynthetic, biomorphic, and programmable polymers, which are tailored for tissue reconstruction across various clinical applications. Founded in 2013, TISSIUM is supported by leading healthcare investors and aims to address unmet clinical needs through its groundbreaking approach to wound management.

Incepto

Seed Round in 2019
Incepto Medical SAS, established in 2018 and headquartered in Paris, France, specializes in developing and distributing artificial intelligence (AI) applications for medical imaging. Its portfolio includes software solutions like Qure.ai qER and qXR for head CT and thorax abnormality detection, Aidence Veye Chest for pulmonary nodule tracking, Icometric Icobrain for neurological disorder monitoring, and ScreenPoint Transpara for breast cancer detection. Additionally, Incepto operates Collective Minds Radiology, an online platform fostering case support, opinion sharing, and learning among healthcare professionals. The company aims to empower medical practitioners by providing AI-driven tools that address the challenges posed by increasing patient volumes and image data.

cozycozy.com

Venture Round in 2019
Cozycozy is a search engine that allows travelers to compare the full range of available accommodation options, ensuring that they find the place that best meets their needs and always at the best price. It allows users to search for all available accommodation options in one place, including hotels, apartments, houses, youth hostels, lodges, boats, tree houses, cottages, cabins, and more.

Algaia

Acquisition in 2019
Algaia is engaged in the development, production, and commercialization of natural extracts primarily derived from seaweed. The company provides a diverse array of sustainable products and solutions tailored for the agro-nutrition, personal care, and pharmaceutical industries. Following its acquisition of Alganact SA, Algaia has expanded its offerings to include a service division that assists clients in understanding the potential of their seaweed biomass and characterizing their extracts. By utilizing eco-friendly proprietary biotechnologies, Algaia produces natural extracts that serve as stabilizing and thickening agents, enhancing water retention for various applications in agro-nutrition, personal care, and nutraceutical sectors.

Implicity

Seed Round in 2019
Implicity is a developer of a remote monitoring platform that focuses on patients with connected cardiac implants, such as pacemakers and defibrillators. The company's software-as-a-service (SaaS) platform utilizes artificial intelligence to sort and summarize patient data, assessing the criticality of alerts based on the medical context of each individual. This technology allows cardiologists and healthcare professionals to automate the monitoring process, facilitating efficient oversight of patient health and enhancing the quality of care. By consolidating patient information and alerts on a single platform, Implicity aims to improve the management of cardiac conditions and support hospital teams in delivering optimal patient outcomes.

Misakey

Seed Round in 2019
Misakey SAS, founded in 2018 and based in Paris, France, specializes in the design and development of a personal data protection platform aimed at helping individuals manage their digital lives. The company's online platform allows users to access and control their personal data across various social media platforms, facilitating the recovery of data and enabling requests for updates, deletions, limitations, and freezing of information. By providing these services, Misakey empowers citizens to reclaim control over their personal data and enhance their online privacy. Additionally, the platform supports webmasters in integrating applications and creating compliant websites, further contributing to a secure digital environment.

Admo.tv

Series B in 2019
Admo.tv is the best TV analytics platform that helps TV & radio advertisers to measure and optimise the online impact of their offline investments. Admo.tv optimises, in average, about 30% the R.O.I. of its clients by providing the finest analysis in terms of incremental visits and conversion of their media investments. Admo.tv is a start-up that has offices in Paris and operates in more than 12 different countries worldwide. Admo.tv optimise every day the offline investments of the best advertising agencies (Dentsu Aegis, Havas…) and top-tier brands such as Accor, Allianz, Ford, Meetic, La Redoute, and more.

Acticor Biotech

Series B in 2018
Acticor Biotech SAS is a clinical-stage biopharmaceutical company based in Paris, France, founded in 2013. The company specializes in developing innovative therapeutic monoclonal antibodies aimed at treating acute thrombotic diseases, particularly focusing on acute ischemic stroke. Its lead product, Glenzocimab, is a humanized antibody designed to address the critical need for new therapeutic options in the management of stroke, a condition that affects millions globally each year and leads to significant mortality and disability. Currently, existing treatments for ischemic stroke have limited efficacy and reach, highlighting the urgent demand for more effective solutions. Acticor Biotech is dedicated to advancing its novel therapies to meet this pressing medical need.

Acticor Biotech

Series B in 2018
Acticor Biotech SAS is a clinical-stage biopharmaceutical company based in Paris, France, founded in 2013. The company specializes in developing innovative therapeutic monoclonal antibodies aimed at treating acute thrombotic diseases, particularly focusing on acute ischemic stroke. Its lead product, Glenzocimab, is a humanized antibody designed to address the critical need for new therapeutic options in the management of stroke, a condition that affects millions globally each year and leads to significant mortality and disability. Currently, existing treatments for ischemic stroke have limited efficacy and reach, highlighting the urgent demand for more effective solutions. Acticor Biotech is dedicated to advancing its novel therapies to meet this pressing medical need.

Wisebatt

Seed Round in 2018
Wisebatt SAS is a French company established in 2016 that specializes in developing a web-based simulation platform for electronic engineers focused on Internet of Things (IoT) devices. The platform enables users to create virtual prototypes and conduct power analysis and optimization of battery-powered devices early in the design process. By providing complex modeling results within minutes, Wisebatt allows hardware engineers to make informed decisions regarding cost, battery life, and performance, significantly reducing the time typically required for such analyses. The technology behind Wisebatt's platform is rooted in over 15 years of academic research, making it a valuable tool for original equipment manufacturers, hardware and software designers, and service providers seeking to enhance the reliability and sustainability of their products.

Wisebatt

Seed Round in 2018
Wisebatt SAS is a French company established in 2016 that specializes in developing a web-based simulation platform for electronic engineers focused on Internet of Things (IoT) devices. The platform enables users to create virtual prototypes and conduct power analysis and optimization of battery-powered devices early in the design process. By providing complex modeling results within minutes, Wisebatt allows hardware engineers to make informed decisions regarding cost, battery life, and performance, significantly reducing the time typically required for such analyses. The technology behind Wisebatt's platform is rooted in over 15 years of academic research, making it a valuable tool for original equipment manufacturers, hardware and software designers, and service providers seeking to enhance the reliability and sustainability of their products.

TRiCares

Series B in 2018
TRiCares is a medical device company focused on creating innovative solutions for tricuspid valve regurgitation. The company specializes in developing a catheter-based valve replacement system that facilitates minimally invasive treatments for patients suffering from tricuspid insufficiency. By emphasizing anatomical conformation and user-friendly design, TRiCares aims to provide effective and durable treatment options that improve patient outcomes. Through its advancements in medical technology, TRiCares addresses a critical need in cardiology, enhancing the quality of care for those affected by this condition.

Serious Factory

Series A in 2018
Serious Factory is a French software company established in 2007, specializing in developing training simulators for corporate clients. The company offers Virtual Training Suite, a SaaS solution that complements traditional learning methods, serving diverse industries such as aerospace, automotive, banking, and retail through partner resellers across Europe, Asia, and North America. Serious Factory's expertise lies in instructional engineering and gamification, enabling businesses to enhance their training programs by acquiring knowledge through digital modules, developing skills via practical exercises, and monitoring progress using skill tracking tools.

Appscho

Seed Round in 2018
AppScho, SAS, established in 2014 and headquartered in Paris, France, specializes in mobile application software for higher education. Its application centralizes essential information for students and educational institutions, providing access to schedules, grades, school events, and employment opportunities. The app enhances student engagement by offering features such as course previews, classroom details, and notifications for schedule changes. Additionally, it facilitates communication between institutions and students, allowing educators to monitor student engagement and analyze performance. By streamlining campus content and services, AppScho aims to improve the overall academic experience and support students in managing their studies effectively.

Pherecydes Pharma

Series B in 2018
Pherecydes Pharma SA is a biotechnology company based in Romainville, France, that specializes in the research and development of lytic bacteriophages for therapeutic and diagnostic purposes, particularly in the context of antibiotic resistance. Established in 2006, the company is dedicated to creating personalized phage therapies aimed at treating bacterial infections. It has developed several banks of bacteriophages, including those targeting Escherichia coli, and has initiated multicenter clinical trials across Europe to assess the efficacy of phage therapy in treating infected burn wounds. By harnessing the natural ability of bacteriophages to infect and eliminate bacteria without affecting human cells, Pherecydes Pharma aims to provide innovative solutions for combating a wide range of bacterial threats, including multi-resistant and emergent strains.

Acticor Biotech

Series A in 2018
Acticor Biotech SAS is a clinical-stage biopharmaceutical company based in Paris, France, founded in 2013. The company specializes in developing innovative therapeutic monoclonal antibodies aimed at treating acute thrombotic diseases, particularly focusing on acute ischemic stroke. Its lead product, Glenzocimab, is a humanized antibody designed to address the critical need for new therapeutic options in the management of stroke, a condition that affects millions globally each year and leads to significant mortality and disability. Currently, existing treatments for ischemic stroke have limited efficacy and reach, highlighting the urgent demand for more effective solutions. Acticor Biotech is dedicated to advancing its novel therapies to meet this pressing medical need.

Precogs

Venture Round in 2017
Precogs is a business analytics company based in Paris, France, founded in 2011. It specializes in providing solutions for supply risk management, enterprise resource planning, and procurement monitoring. The company offers innovative products such as CogWatch, a big data predictive tool designed for analytics, and Cog Margin, a component pricing platform. Precogs focuses on serving EMS-ODM-OEM businesses by delivering real-time information on the best available prices for electronic components, enhancing their decision-making processes and operational efficiency.

PayinTech

Venture Round in 2017
PayinTech is a fintech company established in 2010 by Bertrand Sylvestre-Boncheval and Jean-Rémi Kouchakji, specializing in cashless payment solutions. Initially developed for a student bar, the technology has evolved to support large-scale events, notably the Hadra Trance Festival, which became Europe's first fully cashless festival in 2012, managing payments for 14,000 attendees. With significant investments in research and development, PayinTech has diversified its offerings across various private payment markets. The company focuses on simplifying transactional processes while enhancing revenue generation for corporate clients and improving user experiences. PayinTech's innovative solutions include IoT-based cashless payment software and electronic wristbands that facilitate seamless transactions at events and venues. The company serves a wide range of clients, including resorts, amusement parks, stadiums, local authorities, and NGOs, operating in 16 countries across Europe, Africa, the Middle East, Latin America, and Southeast Asia.

Acticor Biotech

Venture Round in 2017
Acticor Biotech SAS is a clinical-stage biopharmaceutical company based in Paris, France, founded in 2013. The company specializes in developing innovative therapeutic monoclonal antibodies aimed at treating acute thrombotic diseases, particularly focusing on acute ischemic stroke. Its lead product, Glenzocimab, is a humanized antibody designed to address the critical need for new therapeutic options in the management of stroke, a condition that affects millions globally each year and leads to significant mortality and disability. Currently, existing treatments for ischemic stroke have limited efficacy and reach, highlighting the urgent demand for more effective solutions. Acticor Biotech is dedicated to advancing its novel therapies to meet this pressing medical need.

Ugloo

Venture Round in 2017
Ugloo is a developer of an innovative data storage and backup platform that provides a robust solution for securing important information. The company's technology allows businesses to optimize existing infrastructure by upgrading available space into a virtual rack, enabling efficient data management without the need for additional investments. This approach ensures that organizations maintain complete governance over their data while facilitating the seamless transfer and sharing of large files across various platforms. By reusing available space, Ugloo offers a cost-effective and indestructible solution to data storage challenges.

Nexdot

Venture Round in 2016
Nexdot is a company specializing in the development and production of semiconductor nanocrystals known as Quantum Dots, with a particular focus on nanoplatelets—two-dimensional nanosheet Quantum Dots that exhibit enhanced properties. Originating as a spin-off from a renowned academic laboratory in Paris, Nexdot leverages over a decade of expertise in nanomaterial research. The company has invested four years in intensive research and development to establish unique capabilities in the synthesis of colloidal Quantum Dots and Nanoplatelets. Their proprietary materials, characterized by controlled shape and composition, are designed for a variety of applications, including displays, lighting, energy storage, detectors, and bio-imaging. Nexdot combines a team of highly skilled, passionate scientists with seasoned executives who possess a strong background in management and innovation leadership, positioning the company as a leader in the field.

Restlet

Convertible Note in 2016
Restlet offers a comprehensive API-First Platform as a Service, enabling developers and non-developers alike to design, document, test, and host APIs efficiently. Its platform facilitates enterprise-level API projects, making cloud, mobile, web, and IoT application development simpler and more secure. Additionally, Restlet maintains the widely-used open-source REST API framework, Restlet Framework, fostering growth in the API development community. Recognized by Gartner as a Cool Vendor in Specialized PaaS in 2015, Restlet is headquartered in San Mateo, California, with an engineering office in Nantes, France.

TRiCares

Seed Round in 2016
TRiCares is a medical device company focused on creating innovative solutions for tricuspid valve regurgitation. The company specializes in developing a catheter-based valve replacement system that facilitates minimally invasive treatments for patients suffering from tricuspid insufficiency. By emphasizing anatomical conformation and user-friendly design, TRiCares aims to provide effective and durable treatment options that improve patient outcomes. Through its advancements in medical technology, TRiCares addresses a critical need in cardiology, enhancing the quality of care for those affected by this condition.

Linkfluence

Series C in 2016
Linkfluence is a social media intelligence company that focuses on analyzing online conversations to create business opportunities for brands. Its flagship product, the Radarly Product Suite, is a user-friendly, multilingual SaaS tool designed for monitoring and measuring social media interactions. This platform collects relevant conversations about brands, providing actionable insights that can be utilized across various organizational functions. Linkfluence's solutions address needs such as reputation management, influencer engagement, community management, crisis detection, and trend analysis. The company has successfully assisted over 200 prominent brands in Europe to enhance their social media strategies, leveraging data to optimize brand performance and inform decision-making.

NAVYA

Series B in 2016
Navya SA is a prominent French company specializing in autonomous vehicle technology and smart shared mobility solutions. Founded in 2014 and headquartered in Villeurbanne, France, Navya develops, manufactures, and services a range of driverless electric vehicles, including autonomous shuttles and cabs. The company primarily caters to municipalities, industrial sites, universities, theme parks, and airports, and its products are available in the United States, EMEA, and Asia-Pacific regions. Navya has been a pioneer in the autonomous mobility sector, launching its first shuttle, the AUTONOM®SHUTTLE, in 2015, with over 100 units produced and sold in multiple countries. The AUTONOM®CAB, introduced in 2017, is set to undergo road tests soon. With a workforce of more than 200 employees in France and the United States, Navya combines advanced robotic and digital technologies to deliver innovative mobility solutions.

Stootie

Series A in 2016
Stootie is a mobile classifieds platform that focuses on facilitating peer-to-peer transactions in real-time. Designed for convenience, it allows users to quickly buy and sell items or services locally. Whether someone needs a phone charger while working at a café or seeks assistance with household tasks, Stootie serves as a practical tool for these immediate needs. It is recognized as the leading app for peer-to-peer services in France and is accessible on both iOS and Android devices. The platform emphasizes a user-friendly experience, making it easy for individuals to connect and transact efficiently.

Playtem

Venture Round in 2016
Playtem is a company focused on revolutionizing the advertising landscape through innovative in-game native formats. Led by a team of passionate entrepreneurs, Playtem develops a video game monetization platform that connects a vast audience of gamers with their favorite brands. The platform aims to foster an emotional connection between players and brands, enhancing user experience while delivering impactful advertising solutions. By enabling gaming brands to engage with players on a daily basis across web and mobile, Playtem seeks to create meaningful interactions that benefit both advertisers and the gaming community.

Stereolabs

Venture Round in 2016
Stereolabs Inc. is a technology company specializing in 3D depth sensing solutions for autonomous robotics and augmented reality applications. Founded in 2006 and headquartered in San Francisco, California, with an additional office in Sheung Wan, Hong Kong, Stereolabs develops the ZED Stereo Camera, which utilizes passive stereo vision to enable depth perception and motion analysis akin to human vision. This technology has been widely adopted by developers and major game makers, facilitating mixed-reality experiences in virtual and augmented reality environments. Additionally, Stereolabs is known for Linq, a mixed reality headset that enhances gaming experiences by seamlessly merging real and virtual worlds. The company's innovations also extend to providing software tools for the broadcast and film industry, offering advanced features for live analysis and stereo3D footage processing.

Nexdot

Venture Round in 2016
Nexdot is a company specializing in the development and production of semiconductor nanocrystals known as Quantum Dots, with a particular focus on nanoplatelets—two-dimensional nanosheet Quantum Dots that exhibit enhanced properties. Originating as a spin-off from a renowned academic laboratory in Paris, Nexdot leverages over a decade of expertise in nanomaterial research. The company has invested four years in intensive research and development to establish unique capabilities in the synthesis of colloidal Quantum Dots and Nanoplatelets. Their proprietary materials, characterized by controlled shape and composition, are designed for a variety of applications, including displays, lighting, energy storage, detectors, and bio-imaging. Nexdot combines a team of highly skilled, passionate scientists with seasoned executives who possess a strong background in management and innovation leadership, positioning the company as a leader in the field.

Comiteo

Venture Round in 2016
Comitéo, established in 2008, specializes in developing innovative services tailored for works councils. The company offers a web platform and mobile application that streamline daily management tasks and enhance communication. Its software is designed to simplify operations while providing employees with access to exclusive offers and promotions from various brands. Additionally, Comitéo's platform manages the accounting and budgeting for works councils, contributing to employee satisfaction and supporting revenue growth for clients. Overall, Comitéo aims to facilitate the roles of elected representatives by providing an intuitive and configurable solution that integrates technology, culture, and recreation.

Restlet

Convertible Note in 2016
Restlet offers a comprehensive API-First Platform as a Service, enabling developers and non-developers alike to design, document, test, and host APIs efficiently. Its platform facilitates enterprise-level API projects, making cloud, mobile, web, and IoT application development simpler and more secure. Additionally, Restlet maintains the widely-used open-source REST API framework, Restlet Framework, fostering growth in the API development community. Recognized by Gartner as a Cool Vendor in Specialized PaaS in 2015, Restlet is headquartered in San Mateo, California, with an engineering office in Nantes, France.

Sevenhugs

Seed Round in 2016
Sevenhugs Inc. is a company specializing in ultra-wideband (UWB) systems for indoor positioning and orientation tracking. Founded in 2014 and based in San Francisco, California, Sevenhugs develops software solutions for smartphone, IoT device, and automotive manufacturers. The company is best known for its Smart Remote, which serves as a universal control for televisions and smart home devices, allowing users to manage various functions through a single adaptive interface. In addition to its remote control products, Sevenhugs offers features such as access and security, spatial context, precision air mouse, and secure localization API, all designed to enhance the smart home experience. As of October 2020, Sevenhugs operates as a subsidiary of Qorvo, Inc.

BnbSitter

Series A in 2016
BnbSitter, established in 2013 and headquartered in Paris, France, specializes in streamlining short-term rental management. Through its online platform, the company offers on-demand concierge services, enabling vacation rental hosts to book essential services like guest check-in/check-out and rental cleaning swiftly and efficiently, ensuring a smooth and welcoming experience for guests.

TISSIUM

Series A in 2016
TISSIUM is a medical device company headquartered in Paris, France, focused on the development and commercialization of innovative biodegradable sealants and adhesives for surgical wound closure, particularly in minimally invasive procedures. The company's products are designed to be non-toxic, provide strong adhesion to tissues, and enable rapid wound closure in the body's dynamic environments. TISSIUM leverages advanced research and intellectual property from renowned laboratories, including those of Robert Langer at MIT and Jeff Karp at Brigham and Women’s Hospital. Its technology platform includes a proprietary family of fully biosynthetic, biomorphic, and programmable polymers, which are tailored for tissue reconstruction across various clinical applications. Founded in 2013, TISSIUM is supported by leading healthcare investors and aims to address unmet clinical needs through its groundbreaking approach to wound management.

Melusyn

Seed Round in 2016
Melusyn offers an interactive platform that enables film product crews to keep track of and optimize their schedules. It enables teams to communicate with each other; keep track of decorations, casting, and costumes; keep track of time; and more. Melusyn is based in Paris, France.

NAVYA

Venture Round in 2016
Navya SA is a prominent French company specializing in autonomous vehicle technology and smart shared mobility solutions. Founded in 2014 and headquartered in Villeurbanne, France, Navya develops, manufactures, and services a range of driverless electric vehicles, including autonomous shuttles and cabs. The company primarily caters to municipalities, industrial sites, universities, theme parks, and airports, and its products are available in the United States, EMEA, and Asia-Pacific regions. Navya has been a pioneer in the autonomous mobility sector, launching its first shuttle, the AUTONOM®SHUTTLE, in 2015, with over 100 units produced and sold in multiple countries. The AUTONOM®CAB, introduced in 2017, is set to undergo road tests soon. With a workforce of more than 200 employees in France and the United States, Navya combines advanced robotic and digital technologies to deliver innovative mobility solutions.

Restlet

Convertible Note in 2015
Restlet offers a comprehensive API-First Platform as a Service, enabling developers and non-developers alike to design, document, test, and host APIs efficiently. Its platform facilitates enterprise-level API projects, making cloud, mobile, web, and IoT application development simpler and more secure. Additionally, Restlet maintains the widely-used open-source REST API framework, Restlet Framework, fostering growth in the API development community. Recognized by Gartner as a Cool Vendor in Specialized PaaS in 2015, Restlet is headquartered in San Mateo, California, with an engineering office in Nantes, France.

MOPeasy

Venture Round in 2015
MOPeasy, ecomobility operator, provides solutions for car sharing of electric vehicules and others, car pooling and access and reservations for charging stations, all in one platform. THE community solution adapted to companies, cities and collective habitats. MOPeasy turns charging stations into mobility stations, operates from 1 to 50 vehicules fleet for a Company. and from 1 station in Rural Communities up to 100 stations across a territory. Interoperable, MOPeasy's platform brings ecomobility solutions for Smart cities.

NAVYA

Seed Round in 2015
Navya SA is a prominent French company specializing in autonomous vehicle technology and smart shared mobility solutions. Founded in 2014 and headquartered in Villeurbanne, France, Navya develops, manufactures, and services a range of driverless electric vehicles, including autonomous shuttles and cabs. The company primarily caters to municipalities, industrial sites, universities, theme parks, and airports, and its products are available in the United States, EMEA, and Asia-Pacific regions. Navya has been a pioneer in the autonomous mobility sector, launching its first shuttle, the AUTONOM®SHUTTLE, in 2015, with over 100 units produced and sold in multiple countries. The AUTONOM®CAB, introduced in 2017, is set to undergo road tests soon. With a workforce of more than 200 employees in France and the United States, Navya combines advanced robotic and digital technologies to deliver innovative mobility solutions.

Mitricares

Seed Round in 2015
MITRICARES aims to develop and market an implantable medical device for percutaneous treatment of tricuspid valves failed. The young company has already realized a first prototype successfully tested several times on the big animal. This new system would address a major public health problem, tricuspid insufficiency, which affects 4 million people in Europe and the USA, with a poor prognosis in the short term.

SetKeeper

Venture Round in 2015
SetKeeper is a developer of a production management software platform designed to enhance the coordination of the physical production process in the audiovisual industry. The platform offers features such as document watermarking and distribution, script sides, and electronic signature services, all aimed at streamlining operational and technical management for projects including films, television shows, broadcasts, commercials, video games, and animation. By leveraging innovative technologies, SetKeeper aims to transform the production landscape and empower clients to optimize their schedules and manage their projects more effectively.

Aterovax

Seed Round in 2015
Aterovax is an in vitro diagnostic company focused on developing innovative solutions for predicting, diagnosing, and preventing cardiovascular disease, with a particular emphasis on atherosclerosis. It creates diagnostic tests that assess the level of atherosclerosis plaque development in patients, enabling healthcare providers to evaluate cardiovascular risk more effectively. By leveraging its unique understanding of atherosclerosis, Aterovax aims to enhance early detection and management of cardiovascular conditions, contributing to improved patient outcomes in heart health.

TRiCares

Seed Round in 2015
TRiCares is a medical device company focused on creating innovative solutions for tricuspid valve regurgitation. The company specializes in developing a catheter-based valve replacement system that facilitates minimally invasive treatments for patients suffering from tricuspid insufficiency. By emphasizing anatomical conformation and user-friendly design, TRiCares aims to provide effective and durable treatment options that improve patient outcomes. Through its advancements in medical technology, TRiCares addresses a critical need in cardiology, enhancing the quality of care for those affected by this condition.

Actvt

Seed Round in 2015
Actvt Inc. is a company focused on revolutionizing social video through innovative video editing technology. It offers a product portfolio that includes an assisted video editing and social networking app called Activity, which allows users to easily select highlights from their footage and automatically create short edits for sharing. This app is available on both iOS and Android platforms. Additionally, Actvt provides Showdown.cc, an in-game replay plugin designed for game developers, enabling players to create, share, and discover gameplay videos. Through these products, Actvt aims to make video content more engaging and accessible for users.

Prestodiag

Series A in 2015
Prestodiag specializes in the development, manufacture, and sale of innovative solutions for the rapid detection of pathogenic bacteria. Utilizing advanced Surface Plasmon Resonance imaging technology, the company offers analytical systems that can identify harmful bacteria such as Salmonella, Listeria, and E. coli within hours, significantly faster than traditional methods that may take days. Prestodiag primarily serves the food safety industry, but its applications extend to medical and environmental sectors as well. By enabling early detection of microbiological pathogens in complex matrices, the company's solutions help businesses enhance product safety and increase shelf life.

Melusyn

Seed Round in 2015
Melusyn offers an interactive platform that enables film product crews to keep track of and optimize their schedules. It enables teams to communicate with each other; keep track of decorations, casting, and costumes; keep track of time; and more. Melusyn is based in Paris, France.

Eyevensys

Seed Round in 2015
Eyevensys S.A.S. is a Paris-based company that specializes in non-viral gene therapy for ophthalmology. Founded in 2008, it focuses on developing innovative solutions to improve drug delivery methods for ocular diseases. The company utilizes its proprietary Electro-Transfection (ET) technology to administer plasmids to the ciliary muscle, allowing for the sustained release of therapeutic proteins directly into the vitreous, addressing conditions such as uveitis, age-related macular degeneration, and various retinopathies, including central retinal vein occlusion and diabetic retinopathy. Eyevensys aims to overcome the limitations of current treatment options, which often involve invasive procedures like intravitreal injections and surgeries. By enhancing compliance, ocular bioavailability, and tolerability, Eyevensys seeks to create a robust product pipeline that delivers improved clinical outcomes while minimizing the need for frequent and invasive interventions.

RED Technologies

Seed Round in 2015
RED Technologies specializes in spectrum sharing technologies aimed at alleviating spectrum shortages and enhancing access to affordable communication services. The company focuses on dynamic spectrum access for private 5G networks, offering scalable cloud-based solutions that enable telecommunications operators to modernize their infrastructures efficiently. RED Technologies is also engaged in regulatory developments and standardization efforts to meet the rising demand for accessible 5G services. Its innovative cloud-based spectrum access system facilitates spectrum sharing based on a three-tier hierarchy, ensuring proper user protection and efficient sharing in a multi-tiered framework.

OpenOcean

Seed Round in 2015
OpenOcean is a venture capital firm established in 2008, with offices in Helsinki and London. It specializes in early-stage investments, particularly targeting Series A funding for technology companies within the data economy across Europe, with a focus on sectors such as B2B platforms, cybersecurity, fintech, artificial intelligence, and cloud technology. The firm is driven by three core investment theses: Automation, Data Infrastructure, and the Future of Software Development, with initial average investments around €5 million. The founding team includes key figures behind MySQL and MariaDB, providing OpenOcean with a strong technical background that enables them to identify and invest in innovative startups with scalable solutions. By leveraging their expertise in technology and software, OpenOcean aims to support the growth of transformative digital platforms and services.

English Attack

Series A in 2015
English Attack is a Web 2.0, entertainment-driven English language learning Entertainment Learning was created to bring leverage the power of digital entertainment to transform the way people learn. Its flagship service, English Attack! (www.english-attack.com) creates true innovation in the $35 billion market for English language learning via a 100% entertainment-driven approach to helping learners increase and enhance their exposure to, and use of, the language. It achieves this via interactive lessons based on clips from blockbuster movies, hit TV series, and television news reports; chart-topping music videos; professionally produced casual games; visual dictionaries; and a global social network of learners of English. Entertainment Learning was founded by experienced digital entertainment executives Paul Maglione and Frederic Tibout, who launched English Attack! commercially in 2012 after the service had won or been a finalist in several French and European startup competitions including Plugg Brussels, The Next Web Amsterdam, and Seedcamp Paris.

Serious Factory

Seed Round in 2015
Serious Factory is a French software company established in 2007, specializing in developing training simulators for corporate clients. The company offers Virtual Training Suite, a SaaS solution that complements traditional learning methods, serving diverse industries such as aerospace, automotive, banking, and retail through partner resellers across Europe, Asia, and North America. Serious Factory's expertise lies in instructional engineering and gamification, enabling businesses to enhance their training programs by acquiring knowledge through digital modules, developing skills via practical exercises, and monitoring progress using skill tracking tools.

VitamFero

Series C in 2015
VitamFero SA is a biotechnology company based in Angers, France, focused on the design, development, registration, and marketing of prophylactic agents, specifically vaccines and neonatal immunostimulants, targeting various infectious diseases. Established in 2005, the company utilizes its patented Toxo Mic1-3KO technology to create innovative vaccines for the treatment of diseases caused by Apicomplexan parasites. Its product portfolio includes vaccines such as VFOtx-251 for ovine toxoplasmosis, VFOne-273 for bovine neosporosis, VFOlh-211 for canine leishmaniasis, and others aimed at equine protozoal myeloencephalitis. With a commitment to advancing veterinary healthcare, VitamFero is dedicated to providing effective solutions against significant infectious threats.

PayinTech

Seed Round in 2015
PayinTech is a fintech company established in 2010 by Bertrand Sylvestre-Boncheval and Jean-Rémi Kouchakji, specializing in cashless payment solutions. Initially developed for a student bar, the technology has evolved to support large-scale events, notably the Hadra Trance Festival, which became Europe's first fully cashless festival in 2012, managing payments for 14,000 attendees. With significant investments in research and development, PayinTech has diversified its offerings across various private payment markets. The company focuses on simplifying transactional processes while enhancing revenue generation for corporate clients and improving user experiences. PayinTech's innovative solutions include IoT-based cashless payment software and electronic wristbands that facilitate seamless transactions at events and venues. The company serves a wide range of clients, including resorts, amusement parks, stadiums, local authorities, and NGOs, operating in 16 countries across Europe, Africa, the Middle East, Latin America, and Southeast Asia.

Stootie

Seed Round in 2015
Stootie is a mobile classifieds platform that focuses on facilitating peer-to-peer transactions in real-time. Designed for convenience, it allows users to quickly buy and sell items or services locally. Whether someone needs a phone charger while working at a café or seeks assistance with household tasks, Stootie serves as a practical tool for these immediate needs. It is recognized as the leading app for peer-to-peer services in France and is accessible on both iOS and Android devices. The platform emphasizes a user-friendly experience, making it easy for individuals to connect and transact efficiently.

Sevenhugs

Seed Round in 2015
Sevenhugs Inc. is a company specializing in ultra-wideband (UWB) systems for indoor positioning and orientation tracking. Founded in 2014 and based in San Francisco, California, Sevenhugs develops software solutions for smartphone, IoT device, and automotive manufacturers. The company is best known for its Smart Remote, which serves as a universal control for televisions and smart home devices, allowing users to manage various functions through a single adaptive interface. In addition to its remote control products, Sevenhugs offers features such as access and security, spatial context, precision air mouse, and secure localization API, all designed to enhance the smart home experience. As of October 2020, Sevenhugs operates as a subsidiary of Qorvo, Inc.

Sevenhugs

Acquisition in 2015
Sevenhugs Inc. is a company specializing in ultra-wideband (UWB) systems for indoor positioning and orientation tracking. Founded in 2014 and based in San Francisco, California, Sevenhugs develops software solutions for smartphone, IoT device, and automotive manufacturers. The company is best known for its Smart Remote, which serves as a universal control for televisions and smart home devices, allowing users to manage various functions through a single adaptive interface. In addition to its remote control products, Sevenhugs offers features such as access and security, spatial context, precision air mouse, and secure localization API, all designed to enhance the smart home experience. As of October 2020, Sevenhugs operates as a subsidiary of Qorvo, Inc.

Open Ocean

Seed Round in 2015
Open Ocean SAS is a French company, established in 2011 and operating out of Brest and Paris, that specializes in developing SaaS-based decision-making platforms for offshore infrastructure and marine operations. The company offers a range of innovative solutions, including the Metocean Analytics tool, which analyzes atmospheric and oceanic conditions, and provides comprehensive reports on tidal energy markets in France. Additionally, Open Ocean produces a spectral wave database to support the development of marine renewable energy in Scotland. Their services include site data analysis, resource and energy assessment, environmental impact assessments, and adherence to greenhouse gas protocols for wave and tidal energy projects. Open Ocean's highly qualified team of oceanographers, trained at leading research institutions, focuses on high-resolution modeling, statistical analysis, and data mining, catering to farm developers, operators, and public agencies in the renewable marine energy sector. As of September 2019, Open Ocean operates as a subsidiary of Artelia SAS.

Pherecydes Pharma

Series A in 2014
Pherecydes Pharma SA is a biotechnology company based in Romainville, France, that specializes in the research and development of lytic bacteriophages for therapeutic and diagnostic purposes, particularly in the context of antibiotic resistance. Established in 2006, the company is dedicated to creating personalized phage therapies aimed at treating bacterial infections. It has developed several banks of bacteriophages, including those targeting Escherichia coli, and has initiated multicenter clinical trials across Europe to assess the efficacy of phage therapy in treating infected burn wounds. By harnessing the natural ability of bacteriophages to infect and eliminate bacteria without affecting human cells, Pherecydes Pharma aims to provide innovative solutions for combating a wide range of bacterial threats, including multi-resistant and emergent strains.

Restlet

Convertible Note in 2014
Restlet offers a comprehensive API-First Platform as a Service, enabling developers and non-developers alike to design, document, test, and host APIs efficiently. Its platform facilitates enterprise-level API projects, making cloud, mobile, web, and IoT application development simpler and more secure. Additionally, Restlet maintains the widely-used open-source REST API framework, Restlet Framework, fostering growth in the API development community. Recognized by Gartner as a Cool Vendor in Specialized PaaS in 2015, Restlet is headquartered in San Mateo, California, with an engineering office in Nantes, France.

Web Geo Services

Seed Round in 2014
Web Geo Services SAS, founded in 2009 and headquartered in Montpellier, France, specializes in online mapping and geolocation technology tailored for various sectors, including retail, e-commerce, travel, banking, and automotive. The company empowers businesses to utilize Google Maps effectively, enhancing customer engagement and driving conversions. As a strategic partner of Google Cloud and recognized as the leading Google Maps partner in Europe, Web Geo Services supports over 400 large enterprises in rapidly deploying digital systems that optimize online checkout and customer journeys. Their flagship platform, Woosmap, offers developers robust Location Intelligence features for mobile apps and websites. Furthermore, Web Geo Services develops cloud-based geolocation solutions that facilitate community engagement and streamline operational processes for businesses, ultimately helping clients boost their revenue through innovative location-based services.

Playtem

Venture Round in 2014
Playtem is a company focused on revolutionizing the advertising landscape through innovative in-game native formats. Led by a team of passionate entrepreneurs, Playtem develops a video game monetization platform that connects a vast audience of gamers with their favorite brands. The platform aims to foster an emotional connection between players and brands, enhancing user experience while delivering impactful advertising solutions. By enabling gaming brands to engage with players on a daily basis across web and mobile, Playtem seeks to create meaningful interactions that benefit both advertisers and the gaming community.

Precogs

Seed Round in 2014
Precogs is a business analytics company based in Paris, France, founded in 2011. It specializes in providing solutions for supply risk management, enterprise resource planning, and procurement monitoring. The company offers innovative products such as CogWatch, a big data predictive tool designed for analytics, and Cog Margin, a component pricing platform. Precogs focuses on serving EMS-ODM-OEM businesses by delivering real-time information on the best available prices for electronic components, enhancing their decision-making processes and operational efficiency.

Rool'in

Seed Round in 2014
Rool'in offers innovative, practical and ecological solutions in the field of bicycle mobility.

Neelogy

Seed Round in 2013
Neelogy SA, established in 2008 and headquartered in Cachan, France, specializes in the development and marketing of precise non-remanence magnetic sensors. These innovative sensors are designed for measuring both alternating and continuous electrical currents, addressing various applications such as energy metering, AC/DC energy conversion, electrical energy storage, and real-time fault detection and diagnostics. Neelogy's technology offers a space-saving and maintenance-free solution that ensures accurate measurements without the need for recalibration, catering to the evolving demands of the energy sector. Since July 2019, Neelogy operates as a subsidiary of Safran Electrical & Power S.A.S.

Axess Vision Technology

Series B in 2013
Axess Vision Technology S.A., founded in 2006 and based in Saint-Pierre-des-Corps, France, specializes in the design and manufacture of disposable sterile endoscopes for various medical applications, including bronchoscopy and urology. The company focuses on enhancing patient safety and comfort while streamlining the work of healthcare practitioners, addressing the evolving challenges in the medical field due to tightening regulations and emerging diseases. Since launching its first single-use endoscope in 2014, Axess Vision has continued to innovate, introducing new visualization systems and filing multiple patents. The company emphasizes its commitment to research and development, collaborating with medical experts to create effective solutions. Additionally, Axess Vision is dedicated to sustainable development and contributing to the local economy, reflecting its social responsibility amidst its growth in the healthcare sector.

TISSIUM

Series A in 2013
TISSIUM is a medical device company headquartered in Paris, France, focused on the development and commercialization of innovative biodegradable sealants and adhesives for surgical wound closure, particularly in minimally invasive procedures. The company's products are designed to be non-toxic, provide strong adhesion to tissues, and enable rapid wound closure in the body's dynamic environments. TISSIUM leverages advanced research and intellectual property from renowned laboratories, including those of Robert Langer at MIT and Jeff Karp at Brigham and Women’s Hospital. Its technology platform includes a proprietary family of fully biosynthetic, biomorphic, and programmable polymers, which are tailored for tissue reconstruction across various clinical applications. Founded in 2013, TISSIUM is supported by leading healthcare investors and aims to address unmet clinical needs through its groundbreaking approach to wound management.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.